Skip to content

The effect of pancreatic duct stent on Post-pancreatectomy acute pancreatitis after pancreatoduodenectomy: a dual center randomized controlled study

The effect of pancreatic duct stent on Post-pancreatectomy acute pancreatitis after pancreatoduodenectomy: a dual center randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101818
Enrollment
Unknown
Registered
2025-04-30
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis after pancreaticoduodenectomy

Interventions

Experimental group:No pancreatic duct stent is placed during pancreatic-intestinal anastomosis
Control group:A pancreatic duct stent is placed during the pancreatic-intestinal anastomosis

Sponsors

The Affiliated BenQ Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Open pancreaticoduodenectomy was performed, and pancreatic-intestinal anastomosis reconstruction was performed after resection; (2) Age>=18 years old, and <=80 years old; (3) The patient voluntarily signs the surgical consent form; (4) Voluntarily participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Preoperative pancreatitis or other conditions that lead to abnormal increase in serum amylase level; (2) Pancreatic-intestinal anastomosis reconstruction was not performed for various reasons, including pancreatic body tail atrophy, previous resection of pancreatic body/body tail, pancreatic-gastric anastomosis reconstruction, etc.; (3) The main pancreatic duct could not be found on the caudal side of the pancreatic body in the pancreatic neck section; (4) The surgeon believed that in order to ensure the safety of patients, it was necessary to place/not place an intraoral stent for transpancreatic-intestinal anastomosis, and randomization could not be carried out; (5) For any reason, the patient is unable to decide whether to participate in this study on his own, or is unable to obtain the patient's informed consent.

Design outcomes

Primary

MeasureTime frame
Incidence of acute pancreatitis after pancreaticoduodenectomy;

Secondary

MeasureTime frame
Surgical complications;

Countries

China

Contacts

Public ContactYi Miao

The Affiliated BenQ Hospital of Nanjing Medical University

miaoyi@njmu.edu.cn+86 158 0518 9988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026